PATENT CLAIM ANALYSIS

Application Number: 15974909
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["514", "249000"]

Abstract:
A novel process for improving neurochemical health includes a multi-day treatment program including intravenous delivery of nicotinamide adenine dinucleotide (NAD) to at least partially restore a patient's brain to a desired chemical balance. Intravenous delivery of NAD is synergistically combined with delivery of selected amino acids and, depending on the ailment being treated, a combination of ozone, testosterone, glutathione, Myers cocktail or other specified compounds.

Claim (Index 8):
The method of  claim 1 , further comprising delivering a second liquid composition to the patient intravenously, the second liquid composition including a plurality of vitamins and a plurality of minerals.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 93.0
- Lexical Diversity: 1.25
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15298735', '12119911', '14624376', '09632838', '15015796']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7297085816292955
- 35 USC 102 Novelty (BERT): 0.4831488366220784
- Combined Prediction Score: 0.7050526071285738
- Mean Citation Score: 142.362718
- Max Citation Score: 152.9796
- Similarity Product: 102.99189563434123

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test